Product Description
Penciclovir is used on the lips and faces of adults to treat cold sores caused by herpes simplex virus. Penciclovir does not cure herpes infections but decreases pain and itching if applied when the earliest symptoms first appear. (Sourced from: https://medlineplus.gov/druginfo/meds/a697027.html)
Mechanisms of Action: HSV Inhibitor, DNA Polymerase Inhibitor, DNA Synthesis Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical, Intravenous
FDA Designation: *
Approval Status: Approved
Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Bulgaria | Canada | Chile | China | Colombia | Cyprus | Czech | Denmark | Egypt | Estonia | Finland | Germany | Greece | Hong Kong | Hungary | Iceland | Ireland | Israel | Italy | Korea | Latvia | Lithuania | Luxembourg | Malta | Netherlands | New Zealand | Norway | Peru | Portugal | Russia | Slovakia | South Africa | Spain | Sweden | Switzerland | Taiwan | Turkey | Ukraine | United Kingdom | United States
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|